Tinospora cordifolia · Giloy · Amrita · Gurcha · Heart-leaved moonseed
500 mg · vegan · gluten-free · 60 caps
Affiliate link · we earn from qualifying purchases. No paid placements.
Guduchi is the dried stem of Tinospora cordifolia, a climbing shrub native to India. It is considered one of the most important rasayana (rejuvenative) herbs in Ayurveda, literally called 'Amrita' (nectar of immortality) for its broad-spectrum health-promoting properties. It has been used for fever, immune modulation, liver support, and as a general tonic for over 3,000 years.
Guduchi contains a polysaccharide rich in glucose, fructose, and arabinose that activates macrophages via TLR6 signaling and NF-κB translocation. It also contains immunomodulatory compounds including tinocordiside, magnoflorine, and cordifolioside A. In HIV-positive patients, it improved symptomatic outcomes despite not significantly changing CD4 counts. It enhances phagocytosis and antibody production in animal models.
Adults seeking traditional Ayurvedic immune support, individuals with recurrent infections, and those interested in classical rasayana therapy. Also used as a vaccination adjunct and in traditional fever management. Not a replacement for ART in HIV or antibiotics in bacterial infections.
Avoid during pregnancy and breastfeeding. Use caution if on immunosuppressive medications (theoretical antagonism). Rare cases of hepatotoxicity have been reported with long-term use of high doses — monitor liver enzymes if using continuously for more than 3 months.
✓ Morning dosing may enhance daytime immune surveillance; evening dosing supports overnight recovery
✓ Morning dosing may enhance daytime immune surveillance; evening dosing supports overnight recovery
✓ Take with meals to reduce the rare risk of gastric irritation and improve tolerability of the bitter preparation
Guduchi contains a polysaccharide rich in glucose, fructose, and arabinose that activates macrophages via TLR6 signaling and NF-κB translocation.
Each bar = one cited trial. Effect varies by methodology, dose, and population.
Representative cohort from published RCT data
Relative to baseline (100). Data from published clinical literature.
Animal study
→ Guduchi extract significantly inhibited the development of adjuvant-induced arthritis in rats and suppressed delayed-type hypersensitivity reactions, confirming immunomodulatory activity.
68
→ Double-blind RCT in 68 HIV-positive patients: 60% on guduchi reported symptomatic improvement versus 20% on placebo; no significant CD4 count change was observed.
Review
→ Comprehensive review documented immunomodulatory, hepatoprotective, antioxidant, and anti-inflammatory properties with low toxicity in preclinical models.
B · One RCT in HIV patients showing symptomatic benefit, plus extensive animal and in vitro data supporting immunomodulation. No large RCTs in healthy adults for general immune enhancement. Hepatotoxicity case reports with long-term use temper enthusiasm for unsupervised continuous dosing.
A plain-English read of the literature behind this supplement. Not a clinical recommendation.
Key citations: Abenavoli 2010 (hepatoprotection systematic review), Cacciapuoti 2013 (NAFLD RCT). richResearch section contains study filters.
How to use Guduchi specifically for Weak immunity — the right dose, timing, blood markers to track, and how to know if it is working.
A clinical evidence review of Guduchi — RCT data, effect sizes, evidence grade, and what the numbers mean for your specific situation.
Everything you need to know about Guduchi — mechanism, dose, safety, buying guide for India, and what the research actually says.
SacredBod's longer take on Guduchi — context the structured blocks above don't capture.
Guduchi is the most celebrated rasayana in Ayurveda — a herb so revered that it is called Amrita, the nectar of immortality. Every traditional physician has stories of its use in fever, immune deficiency, and chronic disease. Modern research has begun to validate some of these claims, but has also raised safety concerns that traditional texts did not anticipate.
The 2008 RCT by Kalikar et al. (PMID 2792597) is the most important human trial. Sixty-eight HIV-positive patients (not on ART) were randomly assigned to receive either Tinospora cordifolia extract 300 mg three times daily or placebo for 6 months. Sixty percent of the guduchi group reported decreased symptoms (fever, cough, fatigue, oral ulcers) versus only 20% of the placebo group. However, objective markers — including CD4 count, total leukocyte count, and hemoglobin — did not show statistically significant differences. The authors concluded that guduchi “could be used as an adjunct to HIV/AIDS management” but not as a standalone therapy.
The 1994 study by Thatte et al. (PMID 8082752) established the immunomodulatory mechanism in rats, showing that guduchi extract inhibited adjuvant-induced arthritis and suppressed delayed-type hypersensitivity. This confirmed that guduchi modulates immune responses rather than simply stimulating them — a key distinction for autoimmune conditions.
The 2010 review (PMID 2924974) by Sharma and Pandey synthesized decades of preclinical work, documenting immunomodulatory, hepatoprotective, antioxidant, radioprotective, and anti-inflammatory effects with low acute toxicity in animal models.
Despite its traditional reputation as a hepatoprotective herb, case reports have emerged of liver injury associated with long-term, high-dose guduchi use. A 2023 review raised concerns about potential hepatotoxicity when used continuously at high doses without medical supervision. This does not invalidate guduchi’s benefits, but it does counsel against unsupervised megadosing or indefinite continuous use. Cycling (e.g., 8-12 weeks on, 2-4 weeks off) and periodic liver enzyme monitoring are prudent for long-term users.
One of the most intriguing applications is as a vaccination adjuvant. A double-blind trial gave guduchi 1500 mg/day or placebo starting on the first day of hepatitis B immunization and continuing for 6 months. The guduchi group produced significantly higher anti-HBsAg antibody titers at 3 and 6 months, along with elevated GM-CSF levels. This suggests guduchi genuinely enhances adaptive immune responses when timed with antigen exposure — a mechanistically plausible and clinically relevant finding.
Classical Ayurveda uses the dried stem (not leaf or root) as Giloy churna (powder) or Guduchi satva (starch extracted from aqueous decoction). The satva is considered the most refined and potent form. Modern capsules typically contain 500 mg of stem extract, but standardization is inconsistent — some products specify bitter principle content, while others are simply crude powder.
For general immune support, ashwagandha has more RCTs in healthy adults. Tulsi has better respiratory-immune data. Amla has stronger antioxidant clinical evidence. Guduchi’s unique niche is in traditional rasayana practice and as a potential vaccination adjunct — areas where its specific immunomodulatory profile may offer genuine advantages. However, the hepatotoxicity signal means it should be used with more caution than most adaptogens.
Peptides are physician-only. Tell us a bit and we'll route you to the right specialist.
